Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Rob Jones

- PMLiVE

Roche eyes filings for Tecentriq/Avastin combo in liver cancer

Another important milestone for Roche's Tecentriq plans

- PMLiVE

Cancer Research UK among partners in new international research alliance

Partners across UK and US will focus on improving early cancer detection

- PMLiVE

Integrating patient reported outcomes into clinical trials

How capturing the patient voice is unlocking medicines’ commercial potential

Roche Basel Switzerland

Roche scores another FDA approval for Xofluza

Expands use to patients at high risk of flu-related complications

- PMLiVE

The best in the UK healthcare system celebrated at QiC Diabetes awards 2019

Award programme recognises work of NHS teams and individuals

- PMLiVE

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal

Initially received a negative opinion of the drug

- PMLiVE

Merck wins CHMP recommendation for Ebola vaccine

Has also been granted priority review by FDA

- PMLiVE

AZ and Daiichi get speedy review for rival to Roche’s HER2 drugs

Could add to AZ's portfolio of emerging cancer drugs

- PMLiVE

A snapshot of Crescendo Biologics

PME talks to CEO Theodora Harold

- PMLiVE

Spotlight interview: 15 minutes on PR in pharma

Vicky Bramham, Managing Director, OPEN Health takes 15 minutes to answer some key questions on PR discipline.

OPEN Health

eyeforpharma Marketing and Customer Innovation Europe

By Richard Springham

Four Agency Worldwide

- PMLiVE

Red Consultancy appoints MD in its health division

Avril Lee brings over 20 years' experience to company

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links